ECE2024 Rapid Communications Rapid Communications 3: Adrenal and Cardiovascular Endocrinology | Part I (7 abstracts)
Combined [18F]Fluorodeoxyglucose PET and [123I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias – The prospective cross-sectional diagnostic test performance study FAMIAN
Stefanie Hahner 1 , Philipp Hartrampf 2 , Felix Beuschlein 3 , Matthias Miederer 4 , Konstanze Miehle 5 , Schlötelburg Wiebke 2 , Carmina Teresa Fuss 1 , Thomas Pflmger 6 , Christian Fottner 7 , Anke Tönjes 5 , Ken Herrmann 8 , Holger Amthauer 9 , Mathias Schreckenberger 4 , Osama Sabri 10 , Johanna Werner 1 , Miriam Reuter 1 , Stefan Kircher 11 , Wiebke Arlt 12 , Martin Fassnacht 1 , Andreas Buck 2 , Hans Helge Müller 13 & Schirbel Andreas 2
1University Hospital Würzburg, Division of Endocrinology and Diabetology, Würzburg; 2University Hospital Würzburg, Department of Nuclear Medicine, Würzburg; 3Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich (USZ) und Universität Zürich (UZH), Switzerland, Switzerland; 4Department of Nuclear Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Germany, Germany; 5University Hospital Leipzig, Medizinische Klinik und Poliklinik III – Endokrinologie, Nephrologie, Rheumatologie, Leipzig, Germany; 6Klinikum der Universität München, Department of Nuclear Medicine, Munich, Germany; 7Department of Endocrinology and Metabolism, I Medical Clinic, University Medical Center of the Johannes Gutenberg University Mainz; 8Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen; German Cancer Consortium (DKTK), Partner Site University Hospital Essen; 9Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nuclear Medicine, 10Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Leipzig, 11Institute of Pathology, University of Würzburg, 12Medical Research Council Laboratory of Medical Sciences, London, UK, 13Institute of Medical Bioinformatics and Biostatistics, Philipps University of Marburg
Adrenal tumours are frequently detected by conventional cross-sectional imaging, which, however, has limited specificity in identifying the most prevalent tumour type, benign, non-functional adrenocortical adenomas (ACA) not requiring surgery. We assessed the diagnostic accuracy of adrenal molecular imaging with [18F]Fluorodeoxyglucose-positron emission tomography (FDG-PET) and [123I]Iodometomidate-single photon emission tomography (IMTO-SPECT). We performed a prospective, multicentre study in adult patients (≥30 years) with indeterminate adrenal masses (diameter >3 cm and unenhanced computed tomography [CT] tumour attenuation ≥10 Hounsfield units [HU]). We assessed the diagnostic performance of combined FDG/IMTO imaging in detecting ACA, using a reference standard of histopathology. Low FDG uptake (=FDG-negative) with high IMTO uptake (=IMTO-positive) was considered indicative of ACA. We also assessed the utility of FDG and unenhanced CT tumour attenuation in detecting malignancy. Between July 2015 and December 2020, 85 patients were enrolled and 77 included in the final analysis; 53 harboured benign and 24 malignant adrenal masses. Combined FDG/IMTO-imaging identified ACA with high specificity (95·7% [95%CI 85·2-99·5%]; positive predictive value 87·5% [95%CI 61·7-98·5%]; positive likelihood ratio 11·1 [95%CI 3·2-122·2%]). However, sensitivity was low (48·3% [95%CI 29·4-67·5%]) due to moderate or high FDG uptake in 14 of 30 ACAs. Malignant masses were identified with high sensitivity but low specificity both by unenhanced CT (cut-off HU≥20 sensitivity 100% [95%CI 85·8-100%], specificity 26·4% [95%CI 15·3-40·3%]) and FDG (sensitivity 95·8% [95%CI 78·9-99·9%], specificity 62·3% [95%CI 47·9-75·2%]). Combined FDG/IMTO-imaging identifies ACA with high specificity in this cohort with indeterminate masses. However, the presence of a sub-cohort of FDG-positive ACA decreases sensitivity.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more